Court rules companies can’t import Gilead medications from overseas
Nikos Pekiaridis | Nurphoto | Getty Images A court ruling this week in favor of Gilead Sciences could significantly impact a burgeoning class of health programs in the U.S. that federal authorities say are illegally importing medications from overseas. Last year, a CNBC investigation found that these programs — called alternative funding programs, or AFPs…
